RDNT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
RadNet Inc (RDNT) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock has strong growth potential, supported by positive financial performance, bullish technical indicators, and favorable analyst ratings. The absence of recent negative news and the hedge fund buying trend further strengthen the case for investment.
The technical indicators for RDNT are bullish. The MACD histogram is positive and expanding, RSI is neutral at 63.286, and moving averages are aligned bullishly (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level (R1: 72.456), with potential upside to R2: 74.71.
Analysts have initiated coverage with an Overweight rating and a $92 price target, citing strong growth drivers like the hospital-to-outpatient shift and AI benefits.
Hedge funds are significantly increasing their positions, with a 139.49% increase in buying over the last quarter.
Financial performance in Q3 2025 shows strong revenue and net income growth, with EPS increasing by 75% YoY.
Gross margin has dropped significantly by -43.90% YoY, which could indicate rising costs or pricing pressures.
No recent congress trading data or news catalysts to provide additional confidence.
RadNet's Q3 2025 financials show strong growth: Revenue increased by 13.39% YoY to $522.87M, Net Income rose by 68.81% YoY to $5.42M, and EPS increased by 75% YoY to $0.07. However, gross margin dropped significantly to 6.25%, down -43.90% YoY.
Analysts are bullish on RDNT. KeyBanc initiated coverage with an Overweight rating and a $92 price target, citing reasonable growth targets, better Medicare rates, and AI benefits. Raymond James maintains a Strong Buy rating, dismissing concerns raised in a short report as overblown.
